Regulatory Roadblock for Zydus: CDSCO Panel Halts MMRV Vaccine Trial, Seeks Adult Data We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
USFDA approves Zydus Lifesciences chronic idiopathic constipation drug Prucalopride We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Zydus Lifesciences on Monday said it has received approval from the US health regulator to market a drug used to treat angina and high blood pressure. The company has received final approval from the US Food and Drug Administration (USFDA) for Diltiazem Hydrochloride tablets in strengths of 30 mg, 60 mg, 90 mg, and 120…
Zydus bags USFDA nod for chronic stable angina drug Diltiazem Hydrochloride We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Zydus Lifesciences gets NOC from Health Canada for ZDS-Varenicline tablets We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Eris Lifesciences looks to leverage its experience in integrated diabetes portfolio to take a lead among the first wave of generic semaglutide anti-diabetic and weight-loss drugs to hit the market early next year, a top official said. The company is looking at a “good” share of the market, Krishnakumar Vaidyanathan, executive director and chief operating…
India’s pharma sector is at a turning point transitioning from a global generics powerhouse to a serious contender in biotech and innovation. In this episode, host Vikas Dandekar is joined by Namita Thapar, Executive Director, Emcure Pharmaceuticals, Aman Mehta, Managing Director, Torrent Pharma, and Sharvil Patel, Managing Director, Zydus Lifesciences to explore what it takes…